Marker Therapeutics Announces Board Resignation

Houston-based biopharmaceutical company Marker Therapeutics, Inc., with a market capitalization of $20.45 million, reported a change in its board composition earlier this week. On Thursday, the firm announced the resignation of Mr. John Wilson from its Board of Directors, effective January 24, 2025. The details surrounding Mr. Wilson's departure have not been disclosed, and the company has not named a successor at this time.

You May Also Be Interested In

• Gulfport Energy and Mobility Global to join S&P SmallCap 600
• Nasdaq closing cross sets record during Russell index rebalancing
• Tractor Supply and Starlink team up to expand rural broadband via 4-H